Medicared For All Logo

Mark Rubenstein in Boca Raton, Florida

Home Florida Boca Raton

Mark Rubenstein has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 1000 Nw 9th Ct in Boca Raton, Florida. There is an additional office location, for a total of two, for Mark Rubenstein that can be viewed further down.

They're a part of the: Bartzokis Rubenstein Servoss Md Pl medical group which has around 7 members. You can call their office at 561-368-4444 to schedule an appointment. , license information, procedures and more. They attended Harvard Medical School and graduated in 1995 (around 29 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Mark H Rubenstein Office Phone and Directions

Mark Rubenstein
Bartzokis Rubenstein Servoss Md Pl
1000 Nw 9th Ct
Boca Raton, Florida 33486
561-368-4444


Patient Ratings
Please rate your experience with Mark Rubenstein below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 561-368-4444


Enter a starting address:


Healthcare Info for Mark Rubenstein

Medical School: Harvard Medical School
Graduation Year: 1995
The Primary Medical Specialty for Mark Rubenstein is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 29
PAC (PECOS ID)#: 6608952866
NPI #: 1457397580
NPI Created On: 06/20/2006
NPI Last Updated Listed as: 10/12/2011
Primary Taxonomy Code: 207RC0000X
License Number:
ME 85150
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  2. Routine ekg using at least 12 leads including interpretation and report
  3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
  4. Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days
  5. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
  6. Evaluation of parameters of leadless, single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report
  7. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
  8. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
  9. Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days
  10. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  11. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  12. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
  13. Ultrasound scan of vena cava or groin graft or vessel blood flow
  14. New patient office or other outpatient visit, typically 45 minutes
  15. Established patient office or other outpatient visit, typically 5 minutes
  16. Established patient office or other outpatient, visit typically 25 minutes
  17. Established patient office or other outpatient, visit typically 25 minutes
  18. Established patient office or other outpatient, visit typically 40 minutes
  19. Hospital observation care, typically 50 minutes
  20. Initial hospital inpatient care, typically 50 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259639

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30


Payments Total: $119

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259645

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259643

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259649

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259653

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: INVOKANA

Open Associated Drug #1: 50458-140-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: XARELTO

Associated Drug #2: 50458-580-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259655

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: INVOKANA

Open Associated Drug #1: 50458-140-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: XARELTO

Associated Drug #2: 50458-580-30


Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259663

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259659

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259665

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788259669

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Additional Office Locations

1. Bartzokis Rubenstein Servoss Md Pl
800 Meadows Rd
Boca Raton, FL 33486
Group Members: 7

Phone: 561-368-4444

Enter a starting address:


Cardiovascular Disease (cardiology) Professionals in Boca Raton

21644 State Rd
Boca-raton, FL
Tenet Florida Physician Services Llc

800 Meadows Rd
Boca-raton, FL
Tenet Florida Physician Services Llc

9980 Central Park Blvd N
Boca-raton, FL
Tenet Florida Physician Services Llc

21644 State Rd
Boca-raton, FL
West Boca Ekg Readers Llc

1000 Nw 9th Ct
Boca-raton, FL
Premier Cardiology Of Boca Raton Llp

800 Meadows Rd
Boca-raton, FL
Boca Raton Ekg Readers Inc

Providers in Bartzokis Rubenstein Servoss Md Pl

1.Thomas Bartzokis

1000 Nw 9th Ct
Boca Raton Fl 33486-2268
Bartzokis Rubenstein Servoss Md Pl
Cardiovascular Disease (cardiology)

2.Thomas Bartzokis

800 Meadows Rd
Boca Raton Fl 33486-2304
Bartzokis Rubenstein Servoss Md Pl
Cardiovascular Disease (cardiology)

3.Debra Becker Md

1000 Nw 9th Ct
Boca Raton Fl 33486-2268
Bartzokis Rubenstein Servoss Md Pl
Cardiovascular Disease (cardiology)

4.Debra Becker Md

800 Meadows Rd
Boca Raton Fl 33486-2304
Bartzokis Rubenstein Servoss Md Pl
Cardiovascular Disease (cardiology)

5.Michael Cammarata

1000 Nw 9th Ct
Boca Raton Fl 33486-2268
Bartzokis Rubenstein Servoss Md Pl
Cardiovascular Disease (cardiology)

6.Barry Merrill

1000 Nw 9th Ct
Boca Raton Fl 33486-2268
Bartzokis Rubenstein Servoss Md Pl
Cardiovascular Disease (cardiology)

View all 7 members of Bartzokis Rubenstein Servoss Md Pl medical group